The phantom smoke smell was the strangest part — waking up at 2am convinced something was burning when nothing was. Nobody mentioned this could be perimenopause, and the neurological rabbit hole that followed before someone connected it to hormones was genuinely frightening. If this is happening to you, you are not imagining it and you are not losing your mind.
Learn more about Rose →The olfactory bulb, the brain structure that first processes scent signals from the nose, contains a high density of estrogen receptors (ERα and ERβ). Estrogen actively modulates both the sensitivity of olfactory neurons and the speed at which scent information is relayed onward to the limbic system. When estrogen levels begin their perimenopausal decline and fluctuation, the calibration of that system shifts — sometimes making smells feel overwhelming, sometimes blunting them almost completely.
Hyperosmia, an abnormally heightened sensitivity to odours, is well-documented during high-estrogen states like early pregnancy, and the same receptor-level mechanism can trigger it during the erratic estrogen spikes that characterise early perimenopause. A woman who previously tolerated cleaning products, candles, or colleagues' lunches without issue may find them suddenly nauseating or headache-inducing. This is not anxiety or sensitivity — it is the nervous system responding in real time to hormonal volatility.
Phantosmia — smelling odours like smoke, burning, or chemicals that have no external source — is reported by a meaningful subset of perimenopausal and menopausal women and is thought to reflect spontaneous, dysregulated firing in olfactory neurons that are no longer being stabilised by consistent estrogen signalling. It can also be linked to migraine activity, which itself increases during perimenopause due to the same hormonal instability. While usually benign in this context, new-onset phantosmia should always be discussed with a doctor to rule out other neurological causes.
A reduction in smell acuity — partial anosmia — shares mechanistic ground with the brain fog that is one of the most commonly reported perimenopausal symptoms. Estrogen has well-established neuroprotective and anti-inflammatory effects across the central nervous system, and as levels fall, low-grade neuroinflammation can affect multiple sensory processing systems simultaneously, including olfaction. A woman noticing both word-retrieval difficulties and a dulled sense of smell at the same time is likely experiencing two expressions of the same underlying neurological shift.
Smell accounts for the majority of what is perceived as taste, so when olfactory sensitivity changes, so does appetite, food enjoyment, and sometimes nutritional intake. Some women in perimenopause report food tasting flat and find themselves gravitating toward saltier or sweeter foods to compensate for reduced sensory reward — a pattern that can quietly work against cardiovascular and metabolic health goals. This is a physiological response, not a willpower issue, and it is worth tracking if unexplained dietary shifts coincide with other perimenopausal symptoms.
Olfactory decline is one of the earliest detectable signs in conditions such as Alzheimer's disease and Parkinson's disease, preceding other cognitive symptoms by years in longitudinal studies. The menopause transition is now understood by researchers to be a neurologically critical period, during which the brain undergoes significant metabolic and structural adaptation to the loss of estrogen's neuroprotective effects. Persistent, progressive smell loss that goes beyond ordinary perimenopausal fluctuation warrants proactive discussion with a neurologist, not as a cause for panic, but because early attention to brain health in this window genuinely matters.
Several studies have found that menopausal hormone therapy (MHT) is associated with improved olfactory sensitivity compared to untreated postmenopausal women, consistent with estrogen's direct role in maintaining olfactory neuron health and signalling efficiency. This is not a reason to start MHT solely for smell changes, but it is meaningful evidence that these changes are hormonally driven rather than coincidental or psychosomatic. For women already weighing the decision about MHT for other symptoms, the olfactory and broader neuroprotective data adds a legitimate dimension to that conversation.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.